⚡️ What’s new in healthcare this week?

CMS pushes interoperability, FDA eyes tighter controls, M&A rebounds, GLP-1 access expands via retail giants, and AI moves from pilots to reimbursement and drug discovery—healthcare’s biggest shifts

Osteoboost develops a FDA-Cleared wearable device designed to improve bone health by delivering targeted mechanical stimulation. Worn around the hips, the device applies low-level vibrations to help maintain or increase bone density, particularly in people at risk of osteoporosis. By offering a non-pharmacological approach, Osteoboost aims to support prevention and early intervention in bone loss.

---

Hey there Insider,

Hope you had a fantastic week!

Here’s your must-read weekly roundup of the latest news and developments in the digital healthcare sector! 👇🏼

1. FDA moves toward easing restrictions on certain peptides.

2. eHealth M&A Deal Volume Increases 21% in Q1:26, according to acquisition data from LevinPro HC.

3. Death by a Thousand Vendors: Solera Report Reveals The Hidden Costs of Digital Health.

4. CMS unveils first wave of health tech tools as it pushes data sharing initiative.

5. Walmart expands Better Care Services to include GLP-1 access.

6. BodySpec partners with longevity telehealth clinic on DEXA scans.

7. Wavelet Medical secures $7M to scale AI fetal brain monitoring globally with Aegis Ventures.

8. Ultralight Raises $9.3M to launch AI-native operating system for healthcare.

9. Abridge partners with medical journals to expand AI clinical decision support.

10. OpenAI partners with Novo Nordisk for AI drug discovery.

11. 6 Health Systems enhancing care delivery with ambient AI Scribes.

April 19-21 | Washington D.C.
AHA’s Annual Membership Meeting.

Until next week, stay connected!

Digital Health Insider.